Bhanji Muna

Bhanji Muna is listed in filings as Director at Cytokinetics, Incorporated - Common Stock. This profile follows SEC Form 4 activity through May 27, 2026, including sale activity. Recent filings connect the profile to Cytokinetics, Incorporated - Common Stock (CYTK), Ardelyx, Inc. (ARDX), Veracyte Inc (VCYT), and Intellia Therapeutics, Inc. (NTLA). The current snapshot covers public activity from Jun 11, 2024 to May 27, 2026. Reported amounts are shown as $331.8K to $122.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.